Evolution of Zebrafish as a Novel Pharmacological Model in Endocrine Research

Simple item page
dc.contributor.authorNavik, Umashanker
dc.contributor.authorRawat, Pushkar Singh
dc.contributor.authorAllawadhi, Prince
dc.contributor.authorKhurana, Amit
dc.contributor.authorBanothu, Anil Kumar
dc.contributor.authorBharani, Kala Kumar
dc.date.accessioned2024-01-21T10:55:03Z
dc.date.accessioned2024-08-14T07:44:20Z
dc.date.available2024-01-21T10:55:03Z
dc.date.available2024-08-14T07:44:20Z
dc.date.issued2022-05-30T00:00:00
dc.description.abstractZebrafish is a powerful platform in the modern era of phenotype-based drug discovery and eminent vertebrate model to study disease progression and its pathophysiology. Zebrafish possess several advantages over rodent model including low cost, females that lay up to 300 eggs per week, the optical clarity of embryo, external fertilization, and highly amenable to transgenic modifications using various genetic toolkits. Zebrafish have almost 70% genetic homology with humans, and 82% of disease-causing human proteins are orthologue to zebrafish. The bottleneck in drug discovery is high cost, laborious, and time taking processes to generate hits. Zebrafish provide a novel option to overcome this bottleneck and have enabled rapid drug discovery in the area of cancer, cardiovascular diseases, endocrine diseases, and many more. However, zebrafish cannot completely replace the mammalian model in drug discovery, but it can form a bridge between cell-based assays and mammalian models, thus reducing the overall cost and time in lead generation. Therefore, in this chapter, we have discussed the role of zebrafish as an emerging vertebrate model in the area of endocrinology disorders. � The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.en_US
dc.identifier.doi10.1007/978-981-16-5217-2_6
dc.identifier.isbn9789811652172
dc.identifier.isbn9789811652165
dc.identifier.urihttp://10.2.3.109/handle/32116/4323
dc.identifier.urlhttps://link.springer.com/10.1007/978-981-16-5217-2_6
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.subjectDiabetesen_US
dc.subjectGonadal hormoneen_US
dc.subjectMutanten_US
dc.subjectObesityen_US
dc.subjectOsteoporosisen_US
dc.subjectThyroiden_US
dc.subjectTransgenicen_US
dc.subjectZebrafishen_US
dc.titleEvolution of Zebrafish as a Novel Pharmacological Model in Endocrine Researchen_US
dc.title.journalZebrafish Model for Biomedical Researchen_US
dc.typeBook chapteren_US
dc.type.accesstypeClosed Accessen_US

Files

Collections

Pharmacology - Research Publications